3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
47.80
+2.75 (6.10%)
At close: Dec 5, 2025
20.86%
Market Cap 3.72B
Revenue (ttm) 324.87M
Net Income (ttm) 133.88M
Shares Out 77.84M
EPS (ttm) 1.71
PE Ratio 27.99
Forward PE n/a
Dividend 0.53 (1.18%)
Ex-Dividend Date Jul 7, 2025
Volume 457,792
Average Volume 151,281
Open 45.15
Previous Close 45.05
Day's Range 45.00 - 48.10
52-Week Range 37.55 - 73.50
Beta 0.29
RSI 62.83
Earnings Date Nov 13, 2025

About 3D Global Biotech

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orth... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.